Clinical Trial Update: Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the Ahmed glaucoma valve alone, with amniotic membrane, or with mitomycin C for refractory glaucoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ahmed glaucoma valve
• Mitomycin-C (mitomycin C)
• amniotic membrane

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Refractory Glaucoma | Phase 1 | Status: UNKNOWN